Social inequalities and long-term health impact of COVID-19 in Belgium: protocol of the HELICON population data linkage.
COVID-19
Health informatics
Public health
SOCIAL MEDICINE
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
18 05 2023
18 05 2023
Historique:
medline:
22
5
2023
pubmed:
19
5
2023
entrez:
18
5
2023
Statut:
epublish
Résumé
Data linkage systems have proven to be a powerful tool in support of combating and managing the COVID-19 pandemic. However, the interoperability and the reuse of different data sources may pose a number of technical, administrative and data security challenges. This protocol aims to provide a case study for linking highly sensitive individual-level information. We describe the data linkages between health surveillance records and administrative data sources necessary to investigate social health inequalities and the long-term health impact of COVID-19 in Belgium. Data at the national institute for public health, Statistics Belgium and InterMutualistic Agency are used to develop a representative case-cohort study of 1.2 million randomly selected Belgians and 4.5 million Belgians with a confirmed COVID-19 diagnosis (PCR or antigen test), of which 108 211 are COVID-19 hospitalised patients (PCR or antigen test). Yearly updates are scheduled over a period of 4 years. The data set covers inpandemic and postpandemic health information between July 2020 and January 2026, as well as sociodemographic characteristics, socioeconomic indicators, healthcare use and related costs. Two main research questions will be addressed. First, can we identify socioeconomic and sociodemographic risk factors in COVID-19 testing, infection, hospitalisations and mortality? Second, what is the medium-term and long-term health impact of COVID-19 infections and hospitalisations? More specific objectives are (2a) To compare healthcare expenditure during and after a COVID-19 infection or hospitalisation; (2b) To investigate long-term health complications or premature mortality after a COVID-19 infection or hospitalisation; and (2c) To validate the administrative COVID-19 reimbursement nomenclature. The analysis plan includes the calculation of absolute and relative risks using survival analysis methods. This study involves human participants and was approved by Ghent University hospital ethics committee: reference B.U.N. 1432020000371 and the Belgian Information Security Committee: reference Beraadslaging nr. 22/014 van 11 January 2022, available via https://www.ehealth.fgov.be/ehealthplatform/file/view/AX54CWc4Fbc33iE1rY5a?filename=22-014-n034-HELICON-project.pdf. Dissemination activities include peer-reviewed publications, a webinar series and a project website.The pseudonymised data are derived from administrative and health sources. Acquiring informed consent would require extra information on the subjects. The research team is prohibited from gaining additional knowledge on the study subjects by the Belgian Information Security Committee's interpretation of the Belgian privacy framework.
Identifiants
pubmed: 37202131
pii: bmjopen-2022-069355
doi: 10.1136/bmjopen-2022-069355
pmc: PMC10200906
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e069355Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
SSM Popul Health. 2021 Apr 16;14:100797
pubmed: 33997246
J Epidemiol Community Health. 2020 Aug;74(8):620-623
pubmed: 32385126
Euro Surveill. 2022 Feb;27(7):
pubmed: 35177167
Arch Public Health. 2021 Oct 27;79(1):188
pubmed: 34706768
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
Epidemiol Perspect Innov. 2007 Dec 04;4:15
pubmed: 18053196
Am J Epidemiol. 2008 Sep 15;168(6):656-64
pubmed: 18682488
Arch Public Health. 2020 Nov 18;78(1):121
pubmed: 33292566
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
J Econ Inequal. 2021;19(3):551-570
pubmed: 34466135
J Clin Epidemiol. 2007 Apr;60(4):350-5
pubmed: 17346608
Epidemiology. 2000 Sep;11(5):550-60
pubmed: 10955408
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Int J Equity Health. 2021 Dec 18;20(1):258
pubmed: 34922557
Euro Surveill. 2021 Jan;26(2):
pubmed: 33446304
Nat Med. 2020 Aug;26(8):1183-1192
pubmed: 32770165
Stat Methods Med Res. 2021 Oct;30(10):2221-2238
pubmed: 34445911
Arch Public Health. 2022 Apr 13;80(1):118
pubmed: 35418097
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Gac Sanit. 2016 Jul-Aug;30(4):293-5
pubmed: 27268023
Euro Surveill. 2021 Dec;26(48):
pubmed: 34857066
Arch Public Health. 2022 Apr 2;80(1):109
pubmed: 35366953
Lancet Infect Dis. 2020 Oct;20(10):1115-1117
pubmed: 32888409
Euro Surveill. 2020 Jul;25(26):
pubmed: 32643601
BMC Palliat Care. 2016 Oct 18;15(1):86
pubmed: 27756296
Stat Methods Med Res. 2022 Sep;31(9):1790-1802
pubmed: 34693801
Ann Oncol. 2021 Jan;32(1):15-19
pubmed: 33096210
PLoS One. 2014 Jun 27;9(6):e101176
pubmed: 24972092